Warning: Parameter 2 to SyndicationDataQueries::posts_search() expected to be a reference, value given in /homepages/8/d142905106/htdocs/old_newsstef78/wp-includes/class-wp-hook.php on line 298

Warning: Parameter 2 to SyndicationDataQueries::posts_where() expected to be a reference, value given in /homepages/8/d142905106/htdocs/old_newsstef78/wp-includes/class-wp-hook.php on line 298

Warning: Parameter 2 to SyndicationDataQueries::posts_fields() expected to be a reference, value given in /homepages/8/d142905106/htdocs/old_newsstef78/wp-includes/class-wp-hook.php on line 298

Warning: Parameter 2 to SyndicationDataQueries::posts_request() expected to be a reference, value given in /homepages/8/d142905106/htdocs/old_newsstef78/wp-includes/class-wp-hook.php on line 298
Leucémie: Novartis publie des nouvelles données positives sur le Tasigna | Les dernières nouvelles

Leucémie: Novartis publie des nouvelles données positives sur le Tasigna


Warning: Parameter 2 to SyndicationDataQueries::posts_search() expected to be a reference, value given in /homepages/8/d142905106/htdocs/old_newsstef78/wp-includes/class-wp-hook.php on line 298

Warning: Parameter 2 to SyndicationDataQueries::posts_where() expected to be a reference, value given in /homepages/8/d142905106/htdocs/old_newsstef78/wp-includes/class-wp-hook.php on line 298

Warning: Parameter 2 to SyndicationDataQueries::posts_fields() expected to be a reference, value given in /homepages/8/d142905106/htdocs/old_newsstef78/wp-includes/class-wp-hook.php on line 298

Warning: Parameter 2 to SyndicationDataQueries::posts_request() expected to be a reference, value given in /homepages/8/d142905106/htdocs/old_newsstef78/wp-includes/class-wp-hook.php on line 298
Le groupe pharmaceutique Novartis a publié des résultats d'essais cliniques de phase III qui ont de nouveau démontré la supériorité de son médicament Tasigna par rapport à son anticancéreux Glivec pour traiter une forme de cancer du sang.

Laisser un commentaire

Votre adresse de messagerie ne sera pas publiée. Les champs obligatoires sont indiqués avec *

© Les dernières nouvelles
CyberChimps